Kexing Biopharm Co., Ltd. (SHA:688136)
China · Delayed Price · Currency is CNY 21.71
+0.92 (4.43%)
Jul 15, 2026, 3:00 PM CST
Kexing Biopharm Market Cap
Kexing Biopharm has a market cap or net worth of 4.11 billion as of July 15, 2026. Its market cap has decreased by -52.72% in one year.
Market Cap
4.11B
Enterprise Value
4.90B
Revenue
1.46B
Ranking
n/a
PE Ratio
36.65
Stock Price
21.71
Market Cap Chart
Since December 14, 2020, Kexing Biopharm's market cap has decreased from 8.15B to 4.11B, a decrease of -49.52%. That is a compound annual growth rate of -11.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 4.11B | -34.44% |
| Dec 31, 2025 | 6.27B | 45.13% |
| Dec 31, 2024 | 4.32B | 7.17% |
| Dec 29, 2023 | 4.03B | -5.31% |
| Dec 30, 2022 | 4.26B | -24.16% |
| Dec 31, 2021 | 5.62B | -30.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 14, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition